NCT02874014 Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer Status COMPLETED Phase PHASE2
NCT02873013 Asia Study Group of Prostate Cancer (A-CaP Study) Status ENROLLING_BY_INVITATION Phase N/A
NCT02871752 Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education Status COMPLETED Phase NA
NCT02869282 Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer Status WITHDRAWN Phase N/A
NCT02867020 Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels Status COMPLETED Phase PHASE2
NCT02865330 Spanish Urological Association Registry of Patients on Active Surveillance Status RECRUITING Phase N/A
NCT02861209 Collaborative Network to Take Responsibility for Oral Anticancer Therapy Status UNKNOWN Phase NA
NCT02858128 WB-DW-MRI vs CHOLINE-PET/CT for Selecting Treatments in Recurrent Prostate Cancer Status COMPLETED Phase N/A
NCT02856100 Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer Status COMPLETED Phase N/A
NCT02853409 Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer Status COMPLETED Phase N/A
NCT02844829 Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and Biomarkers Status UNKNOWN Phase NA
NCT02844699 A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT02844647 Hyperpolarized Carbon-13 Imaging of Metastatic Prostate Cancer Status TERMINATED Phase PHASE1
NCT02840617 ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes Status UNKNOWN Phase PHASE1
NCT02840552 The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer Status COMPLETED Phase PHASE3
NCT02833883 Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT02831920 CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer Status UNKNOWN Phase NA